Perhaps luxury shoes or a bag—but for us, it’s the killer men’s fragrances and (more recently) men's watches. There’s no ...
Lexaria Bioscience (LEXX) provided progress updates on its Phase 1b, 12-week chronic study GLP-1-H24-4 underway in Australia. Lexaria has completed its submission to the human research ethics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback